InsiderTrades

Form 4 for UTHR UNITED THERAPEUTICS Corp

Accepted 2024-05-16 00:00:00 ET · period of report 2024-05-15 · accession 0001415889-24-013352 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-05-16 2024-05-15 UTHR EDGEMOND JAMES CFO AND Treas M - OptEx $163.30 +40.2K 16.7K New +$6.56M
DM 2024-05-16 2024-05-15 UTHR EDGEMOND JAMES CFO AND Treas S - Sale+OE $272.69 -40.2K 1,578 -96% -$10.95M
DM 2024-05-16 2024-05-15 UTHR EDGEMOND JAMES CFO AND Treas M - OptEx $0.00 -40.2K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-15 M A 25,000 $163.30 26,578 D — — (F1) Includes 26, 59, 47, and 62 shares of common stock acquired on September 2, 2022, March 3, 3023, September 1, 2023, and March 4, 2024, respectively, under the United Therapeutics Corporation Employee Stock Purchase Plan.
2 Common Common Stock 2024-05-15 S D 25,000 $272.69 1,578 D — —
3 Common Common Stock 2024-05-15 M A 15,160 $163.30 16,738 D — —
4 Common Common Stock 2024-05-15 S D 15,160 $272.69 1,578 D — —
5 Derivative Share Tracking Award 2024-05-15 M D 15,160 $0.00 0 D $163.30 · 2016-03-13 to 2025-03-13 15,160 Share Tracking Award (F2) Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
6 Derivative Share Tracking Award 2024-05-15 M D 25,000 $0.00 0 D $163.30 · 2016-03-13 to 2025-03-13 25,000 Share Tracking Award (F2) Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.